sgusers9的部落格

Source: Dayton Daily News, OhioSept.迷你倉 05--VANDALIA -- VANDALIA --A local pharmaceutical manufacturer is planning a $4 million addition to its facility, according to the Vandalia's Development & Engineering Services Department.Last month, Aptalis Pharmatech sought a building permit for its center at 845 Center Drive.A representative of the company did not immediately return a phone call by the Dayton Daily News.The company's website states it "manufactures, markets and distributes a broad line of pharmaceutical products and services used in the treatment of cystic fibrosis and gastrointestinal disorders in more than 40 countries, via a combination of its own personnel and a network of global partners."The center in Vandalia is a 110,000-square foot warehouse and plant.In September of last year, Vandalia City Manager Rob Anderson told the Dayton Daily News the company added more than 100 jobs over the last six years.Aptalis is a global company headquartered in Bridgewater, N.J. with fa儲存倉tories in Montreal, Paris and two in Milan.The Vandalia location actually started as a capsular products division of NCR Corp. in the 1950s, when it helped develop carbon-less paper.The encapsulation technology led to other products such as "scratch and sniff" technology and other uses, including pharmaceuticals.By 1984, NCR began divesting itself of subsidiaries, and what became Aptalis last year was owned by several companies, including A.H. Robbins, American Home Products, Phizer, then Eurand.That coating technology used in carbonless paper was reworked as a coating for bitter-tasting pills and as a way to slow down the release of medicine in the body.Now, the company focuses on gastrointestinal diseases and cystic fibrosis, and recently released Viokace, which helps treat exocrine pancreatic insufficiency.Copyright: ___ (c)2013 the Dayton Daily News (Dayton, Ohio) Visit the Dayton Daily News (Dayton, Ohio) at .daytondailynews.com Distributed by MCT Information Services迷你倉價錢